Article in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
4 authors.
Karla M S BragaCardiovascular Research Center, Division of Cardiothoracic Surgery, Department of Surgery, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI 02903, USA.ORCID 0000-0002-8550-0447
Eugenio G AraujoCardiovascular Research Center, Division of Cardiothoracic Surgery, Department of Surgery, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI 02903, USA.ORCID 0000-0002-0242-2827
Frank W SellkeCardiovascular Research Center, Division of Cardiothoracic Surgery, Department of Surgery, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI 02903, USA.
M Ruhul AbidCardiovascular Research Center, Division of Cardiothoracic Surgery, Department of Surgery, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI 02903, USA.ORCID 0000-0003-2981-2638
Funding
Effect of Cardioplegia and Cardiopulmonary Bypass on Coronary Microvascular ReactivityR01HL046716 · NHLBI · RHODE ISLAND HOSPITAL · PI SELLKE, FRANK W · 1997 to 2023
$8.5M
Stem Cells and AgingP30GM145500 · NIGMS · RHODE ISLAND HOSPITAL · PI Patrycja Marta Dubielecka-Szczerba · 2023 to 2026
$6.0M
Vascular Dysfunction in Myocardial Ischemia and Metabolic SyndromeR01HL128831 · NHLBI · RHODE ISLAND HOSPITAL · PI SELLKE, FRANK W, USHEVA-SIMIDJIYSKA, ANNY · 2016 to 2025
$5.7M
Coronary Vascular Resilience by Modulation of Mitochondrial ROS in EndotheliumR01HL175045 · NHLBI · RHODE ISLAND HOSPITAL · PI Ruhul Abid · 2025 to 2026
$1.3M
Sub-cellular Targeting of Endothelial ROS in Myocardial IschemiaR56HL133624 · NHLBI · RHODE ISLAND HOSPITAL · PI ABID, RUHUL · 2022 to 2022
$613k
American Heart Association Visiting Professorship Award 25IVPHA1460933CNPq (National Council for Scientific and Technological Development- Brazil) 208126/2017-1COBRE Stem Cells and Aging of National Institute of Health 5P30GM145500NHLBI NIH HHS R01 HL046716NHLBI NIH HHS R01 HL128831NHLBI NIH HHS R01 HL175045NHLBI NIH HHS R56 HL133624NHLBI NIH HHS R56HL133624NIGMS NIH HHS P30 GM145500Rhode Island Foundation 1472420231352
6 · The paper itself
Abstract
Reactive oxygen species (ROS) overproduction contributes to endothelial dysfunction in Type 2 diabetes mellitus (T2DM). Pequi (
Indexed as
alternative medicinecoronary artery endotheliumendogenous antioxidant enzymeshypoxianatural productstype 2 diabetes
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.